×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Alexion and Novartis/Genentech start UPC's first ever biosimilar disputes
IAM Patent
The patentees join Amgen as the only pharma companies yet to use the pan-European court.
1 week ago
AZ's Alexion debuts short film highlighting NMOSD community
Fierce Pharma
Lights, camera, Alexion! Fresh off an FDA approval for Ultomiris in NMOSD, AstraZeneca's rare disease unit has put out a film sharing...
2 weeks ago
Alexion Pharmaceuticals spotlights rare disease NMOSD in short film
Medical Marketing and Media
Launched on YouTube, Rare Connections in NMOSD seeks to raise awareness of the film through testimonials of three patients living with the...
3 weeks ago
FDA Approves Alexion's Ravulizumab-cwvz for Neuromyelitis Optica Spectrum Disorder
Neurology live
FDA Approves Alexion's Ravulizumab-cwvz for Neuromyelitis Optica Spectrum Disorder ... The approval is supported by phase 3 data which showed...
1 month ago
Alexion leaders talk research, booming biotech industry in New Haven
Yale Daily News
The pharmaceutical firm, which was acquired by AstraZeneca in 2021, specializes in the treatment of rare diseases. The firm has over 500...
5 months ago
FDA approves Alexion's NMOSD treatment Ultomiris
Pharmaceutical Technology
The US FDA has approved Alexion's Ultomiris to treat adults with AQP4 Ab+ neuromyelitis optica spectrum disorder (NMOSD).
1 month ago
Alexion reports positive results from Phase III ATTR-CM trial in Japan
Clinical Trials Arena
Alexion has announced positive outcomes from Japan Phase III trial of acoramidis for transthyretin-mediated amyloid cardiomyopathy...
3 months ago
Alexion Canada Raises Awareness for Rare Diseases Through International colourUp4RARE Campaign
Yahoo Finance
Alexion Pharma Canada Corp., AstraZeneca's Rare Disease group, is marking Rare Disease Day on February 29 by launching colourUp4RARE.
2 months ago
Preclinical Voyager med lands on planet Alexion after larger $1B Pfizer handoff
Fierce Biotech
Preclinical Voyager med lands on planet Alexion after larger $1B Pfizer handoff ... Pfizer has handed off an AAV capsid aimed at a rare...
5 months ago
AstraZeneca’s Alexion Reaches $125M Settlement in Soliris Sales Lawsuit
BioSpace
After nearly seven years, the company's rare diseases arm Alexion has reached a settlement in an investors' lawsuit over alleged unethical...
7 months ago